Erratum to: Characterizing plasma albumin concentration changes in TB/HIV patients on anti retroviral and anti –tuberculosis therapy by unknown
Bisaso et al. In Silico Pharmacology  (2015) 3:2 
DOI 10.1186/s40203-014-0005-7ERRATUM Open AccessErratum to: Characterizing plasma albumin
concentration changes in TB/HIV patients on anti
retroviral and anti –tuberculosis therapy
Kuteesa R Bisaso1*, Joel S Owen2, Francis W Ojara1, Proscovia M Namuwenge3, Apollo Mugisha4,
Lawrence Mbuagbaw5, Livingstone S Luboobi6 and Jackson K Mukonzo1,3,7Erratum
As a result of continuous review of the model published
in (Bisaso et al. 2014) corrections, clarifications and com-
parisons have been made.
1. We would like to retract the relation between
ABCB1c.3435C > T gene mutation and baseline
albumin secretion rate. This is because, even though
the mutation in the gene was identified as a
significant covariate with our data, we are still
unable to biologically explain the relationship.
2. The final model equation (equation 7), referred to
here as the “Simplified Solution” is not the direct
solution of the differential equations preceding it.
We would therefore like replace it with the unsolved
differential equation below and show a comparison
of the results of the two equations.
The unsolved differential equation has the initial value





QSS þ Q0 eRt−1ð Þ
−kX
The equation was fit to the data in NONMEM version
7.2, using a differential equations solver specified by the
ADVAN6 and TOL = 3 subroutines. The First Order
Conditional Estimation with interaction (FOCEI) estima-
tion method was used.
The Interaction term was not used in the previous
analysis because it has been reported not to be useful
when there are small number of observations per indi-
vidual and therefore does not provide different results
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in any medium, provided the original work is pThe two models, i.e. the previously defined simplified
solution and the unsolved differential equation above
were compared with respect to fit, difference and preci-
sion of parameter estimates, goodness of fit, prediction
bias and precision as well as length of runtimes given
the same initial parameter estimates.
As shown in Table 1 below, there was no significant dif-
ference in the fit of the models as measured by Objective
function value (OFV < 3.84). The range of absolute differ-
ence in parameter estimates was 0.28% to 18% of the par-
ameter estimates of the unsolved differential equation
model above. The two models had similar relative stand-
ard errors of the estimates. The prediction bias and preci-
sion were also similar for both models. Both models were
able to identify TB disease status and ABCB1c.3435C > T
genotype as significant covariates on baseline albumin se-
cretion rate. The goodness of fit plots and visual predictive
check plots for both models were indistinguishable. As
shown in Figure 1 and 2 below, the individual and popula-
tion predictions of models were similar.
The total run time (parameter estimation plus covari-
ance) for the unsolved differential equations model
above was more than three times that of the previously
defined model and this ratio was higher during more
intensive procedures like bootstrapping and stepwise
covariate analysis.Conclusion
We would like to change model equation to the un-
solved differential equation model. The model provided
here and the previously defined model differ mostly in
one parameter, R (rate of change of albumin secretion)
and the computation times, but the other outputs
including parameters, predictions and goodness of fit
plots were similar.n Open Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
Table 1 NONMEM estimated relative standard errors,
percentage difference in parameter estimates, numerical
predictive checks and other model comparison criteria











Q0 2.6 2.5 0.28
QSS 18.5 17.3 -0.16
R 48.2 46.0 17.78
Q0_TB = 1(proportional
increase in Q0 with TB)
13.9 14.1 1.27
IIV_Q0 18.0 17.8 0.73
Residual error 5.4 5.4 -0.31
Other model criteria
OFV 57.151 58.457 NA
Condition Number 25.38 21.39 NA
runtime (seconds) 5.48 1.79 NA
Measures of model prediction
Bias (%PE) -0.66478 -0.66329 NA
Precision( 1-RMSE) 0.72481 0.72464 NA
Figure 1 Individual and population model predictions using model 1 (differential equation) versus using model 2 (simplified analytical
solution. The solid black line is the line of identity.
Bisaso et al. In Silico Pharmacology  (2015) 3:2 Page 2 of 3
Figure 2 Visual predictive checks of the two models, stratified on TB disease status. Top panel has the VPC of the previous model and the
bottom panel, the VPC of the unsolved equation.
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